Ke Huang

Assistant Professor of Pharmaceutical Sciences
Contact
Department of Pharmaceutical Sciences
Texas A&M Irma Lerma Rangel College of Pharmacy
1010 W. Ave. B
Kingsville,
TX
78363
kehuang@tamu.edu
Phone: 361.221.0733
Biography
Dr. Ke Huang is an Assistant Professor of Pharmaceutical Sciences at the Texas A&M Irma Lerma Rangel College of Pharmacy. Prior to joining Texas A&M, he served as an Associate Research Scientist in the Department of Biomedical Engineering at Columbia University and as an Assistant Research Professor at North Carolina State University. Dr. Huang earned his MD from Shanxi Medical University in Taiyuan, China, and his PhD in Comparative Biomedical Sciences from North Carolina State University. He subsequently completed postdoctoral training in the Department of Biomedical Engineering at Duke University. His contributions to cardiovascular research have been recognized with several honors, including the American Heart Association (AHA) Career Development Award, the NIH PCTC Outstanding Early Career Investigator Award, the Comparative Medicine Institute Ideation Award, and got Fellow of the American Heart Association (FAHA) in 2023.
Dr. Huang’s teaching interests lie in cell biology, cardiovascular associated physiology, pharmacology, and pathology. Previously, he participated in veterinary and graduate teaching programs and helping graduate students, visiting scientists and professional staff to develop new skills. He also served as lecturer for Fundamentals of Comparative Molecular Medicine, Cell Biology, and Special Topics. After joining Texas A&M, he currently serves as course coordinator for Advanced Pharmacology I and also delivers lectures in courses such as Human Physiology.
His laboratory focuses on engineering cell–derived biotherapeutics for treating cardiac myocardial infarction and ischemia-reperfusion injury. By integrating advanced drug delivery systems and both rodent and large animal disease models, his research bridges fundamental discovery with translational applications. The long-term goal of his program is to develop minimally invasive, cell-free biotherapeutic strategies to address unmet clinical needs in heart repair. His research is currently supported by an NIH R01 grant from NHLBI.
Dr. Huang has authored or coauthored more than 50 publications in high-impact journals, including Science Translational Medicine (cover story, highlighted by Nature Medicine and Nature Reviews Cardiology), Nature Biomedical Engineering, Cell Biomaterials, Circulation, Circulation Research, ACS Nano, Advanced Functional Materials, etc. Additionally, he has served as a grant reviewer for the NIH, AHA, as well as a reviewer for multiple leading scientific journals.